Literature DB >> 33258666

A Study on PHF-Tau Network Effected by Apolipoprotein E4.

Yuan Li1, Zhijun Yao2, Yongqing Yang1, Feng Zhao3, Yu Fu4, Ying Zou5, Bin Hu2.   

Abstract

Apolipoprotein E 4 Allele (APOE 4) is an important factors in Mild cognitive impairment (MCI) and Alzheimer's disease(AD). It plays a primary role in abnormal modification of aggregated Tau protein-paired helical filaments Tau (PHF-Tau). In this study, 143 subjects with PHF-Tau PET were divided into 2 groups (APOE 4 carriers and noncarriers). The measurements of the PHF-Tau network properties and resilient were calculated for 2 group networks respectively. APOE 4 carriers group showed significant differences in all the network properties in the results. We also found significant differences of betweenness centrality in some brain regions for APOE 4 carriers. Moreover, the APOE 4 carriers showed less resilient to targeted or random node failure. Our results indicated that the effects of APOE 4 may lead to abnormalities of PHF-Tau protein network. These findings may be particularly helpful in uncovering the pathophysiology underlying the cognitive dysfunction in MCI patients.

Entities:  

Keywords:  APOE 4; mild cognitive impairment; network properties; network resilience; tau PET brain network

Year:  2020        PMID: 33258666     DOI: 10.1177/1533317520971414

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  2 in total

1.  Brain Network Alterations in Rectal Cancer Survivors With Depression Tendency: Evaluation With Multimodal Magnetic Resonance Imaging.

Authors:  Wenwen Zhang; Ying Zou; Feng Zhao; Yongqing Yang; Ning Mao; Yuan Li; Gang Huang; Zhijun Yao; Bin Hu
Journal:  Front Neurol       Date:  2022-06-29       Impact factor: 4.086

Review 2.  Liposome based drug delivery as a potential treatment option for Alzheimer's disease.

Authors:  Carely Hernandez; Surabhi Shukla
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.